Progression-free survival end points in prostate cancer: are we truly making progress

被引：1
|
作者：
Madan, Ravi A. [1 ]
Posadas, Edwin M. [2 ]
Lee, Richard J. [3 ]
机构：
[1] NCI, Genitourinary Malignancies Branch, Bethesda, MD 20892 USA
[2] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Med Ctr, Los Angeles, CA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Dept Med, Boston, MA USA
来源：
NATURE REVIEWS UROLOGY | 2024年 / 21卷 / 11期
关键词：
PHASE-III; PREDNISONE; CABOZANTINIB; DOCETAXEL; 2ND;
D O I：
10.1038/s41585-024-00902-x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, several therapeutic strategies in prostate cancer have been granted regulatory approval based on progression-free survival benefits alone, which is a relative change in the therapeutic development of prostate cancer treatments. Previously, overall survival was a requirement for approvals. Whether this approach is warranted or beneficial to patients remains unclear.
引用
收藏
页码：646 / 648
页数：3
相关论文
共 50 条
  • [41] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [42] Progression-Free Survival: Helpful Biomarker or Clinically Meaningless End Point?
    Venook, Alan P.
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 4 - U15
  • [43] The validity of progression-free survival 2 as a surrogate trial end point for overall survival
    Woodford, Rachel G.
    Zhou, Deborah D. X.
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian C.
    Simes, R. John
    Lee, Chee Khoon
    CANCER, 2022, 128 (07) : 1449 - 1457
  • [44] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [45] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [46] Progression-free survival or failure of local treatment strategy: End points for trials testing stereotactic body radiotherapy Reply
    Chmura, Steven J.
    Woodward, Wendy A.
    White, Julia R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (04) : 939 - +
  • [47] Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer
    Silva, Ariosto S.
    Kam, Yoonseok
    Khin, Zayar P.
    Minton, Susan E.
    Gillies, Robert J.
    Gatenby, Robert A.
    CANCER RESEARCH, 2012, 72 (24) : 6362 - 6370
  • [48] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [49] ELACESTRANT PROLONGS PROGRESSION-FREE SURVIVAL IN ADVANCED BREAST CANCER
    不详
    CANCER DISCOVERY, 2022, 12 (07) : 1609 - 1609
  • [50] Progression-free survival benefits in triple negative breast cancer
    Fricker, Janet
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (11) : 610 - 610
12345